BioAro Launches PanOmiQ™ Research
AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ Research sets a new global benchmark for precision health innovation. BIO International Convention In a bold move that may redefine the global future of genomics, drug discovery, and precision health, BioAro Inc., a Canadian biotechnology and precision medicine company, unveiled its expanded PanOmiQ platform today at the…
